CASE REPORT
Accepted on 28 Jul 2025
Successful Sequential Treatment with Ofatumumab Followed by Efgartigimod for Refractory Autoimmune Encephalitis with Dual Anti-NMDAR and Anti-GFAP Antibody Positivity: First Case Report
doi 10.3389/fimmu.2025.1640281
- 214 views